Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
BFRG vs ABSI
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
BFRG vs ABSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Biotechnology |
| Market Cap | $7M | $894M |
| Revenue (TTM) | $117K | $2M |
| Net Income (TTM) | $-7M | $-118M |
| Gross Margin | 18.8% | -13.4% |
| Operating Margin | -58.8% | -60.3% |
| Total Debt | $0.00 | $5M |
| Cash & Equiv. | $2.18T | $20M |
BFRG vs ABSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 23 | May 26 | Return |
|---|---|---|---|
| Bullfrog AI Holding… (BFRG) | 100 | 13.6 | -86.4% |
| Absci Corporation (ABSI) | 100 | 271.2 | +171.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BFRG vs ABSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BFRG is the clearest fit if your priority is growth exposure.
- EPS growth 25.9%, 3Y rev CAGR 225.8%
- -2.4% revenue growth vs ABSI's -38.2%
- -57.7% margin vs ABSI's -73.1%
ABSI carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 2.82
- -73.4% 10Y total return vs BFRG's -90.0%
- Lower volatility, beta 2.82, Low D/E 2.8%, current ratio 6.57x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.4% revenue growth vs ABSI's -38.2% | |
| Quality / Margins | -57.7% margin vs ABSI's -73.1% | |
| Stability / Safety | Beta 2.82 vs BFRG's 3.07 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +116.2% vs BFRG's -62.0% | |
| Efficiency (ROA) | -54.7% ROA vs BFRG's -177.1% |
BFRG vs ABSI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BFRG leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ABSI is the larger business by revenue, generating $2M annually — 13.9x BFRG's $116,670. BFRG is the more profitable business, keeping -57.7% of every revenue dollar as net income compared to ABSI's -73.1%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $116,670 | $2M |
| EBITDAEarnings before interest/tax | -$7M | -$116M |
| Net IncomeAfter-tax profit | -$7M | -$118M |
| Free Cash FlowCash after capex | -$6M | -$99M |
| Gross MarginGross profit ÷ Revenue | +18.8% | -13.4% |
| Operating MarginEBIT ÷ Revenue | -58.8% | -60.3% |
| Net MarginNet income ÷ Revenue | -57.7% | -73.1% |
| FCF MarginFCF ÷ Revenue | -48.1% | -60.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.8% | +9.5% |
Valuation Metrics
BFRG leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $7M | $894M |
| Enterprise ValueMkt cap + debt − cash | -$2.18T | $879M |
| Trailing P/EPrice ÷ TTM EPS | -1.03x | -6.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 319.22x |
| Price / BookPrice ÷ Book value/share | 0.00x | 4.15x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
ABSI leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
ABSI delivers a -63.6% return on equity — every $100 of shareholder capital generates $-64 in annual profit, vs $-2 for BFRG. On the Piotroski fundamental quality scale (0–9), ABSI scores 4/9 vs BFRG's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -2.2% | -63.6% |
| ROA (TTM)Return on assets | -177.1% | -54.7% |
| ROICReturn on invested capital | — | -58.0% |
| ROCEReturn on capital employed | -6.2% | -65.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | — | 0.03x |
| Net DebtTotal debt minus cash | -$2.18T | -$15M |
| Cash & Equiv.Liquid assets | $2.18T | $20M |
| Total DebtShort + long-term debt | $0 | $5M |
| Interest CoverageEBIT ÷ Interest expense | -958.75x | -865.97x |
Total Returns (Dividends Reinvested)
ABSI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ABSI five years ago would be worth $2,663 today (with dividends reinvested), compared to $1,000 for BFRG. Over the past 12 months, ABSI leads with a +116.2% total return vs BFRG's -62.0%. The 3-year compound annual growth rate (CAGR) favors ABSI at 59.4% vs BFRG's -42.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -26.2% | +59.3% |
| 1-Year ReturnPast 12 months | -62.0% | +116.2% |
| 3-Year ReturnCumulative with dividends | -81.1% | +304.9% |
| 5-Year ReturnCumulative with dividends | -90.0% | -73.4% |
| 10-Year ReturnCumulative with dividends | -90.0% | -73.4% |
| CAGR (3Y)Annualised 3-year return | -42.6% | +59.4% |
Risk & Volatility
ABSI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ABSI is the less volatile stock with a 2.82 beta — it tends to amplify market swings less than BFRG's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ABSI currently trades 92.2% from its 52-week high vs BFRG's 31.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.07x | 2.82x |
| 52-Week HighHighest price in past year | $2.04 | $6.24 |
| 52-Week LowLowest price in past year | $0.42 | $2.24 |
| % of 52W HighCurrent price vs 52-week peak | +31.8% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 42.2 | 83.6 |
| Avg Volume (50D)Average daily shares traded | 13.6M | 4.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $6.16 |
| # AnalystsCovering analysts | — | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
ABSI leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). BFRG leads in 2 (Income & Cash Flow, Valuation Metrics).
BFRG vs ABSI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is BFRG or ABSI a better buy right now?
Analysts rate Absci Corporation (ABSI) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison.
The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BFRG or ABSI?
Over the past 5 years, Absci Corporation (ABSI) delivered a total return of -73.
4%, compared to -90. 0% for Bullfrog AI Holdings, Inc. Common Stock (BFRG). Over 10 years, the gap is even starker: ABSI returned -73. 4% versus BFRG's -90. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BFRG or ABSI?
By beta (market sensitivity over 5 years), Absci Corporation (ABSI) is the lower-risk stock at 2.
82β versus Bullfrog AI Holdings, Inc. Common Stock's 3. 07β — meaning BFRG is approximately 9% more volatile than ABSI relative to the S&P 500.
04Which is growing faster — BFRG or ABSI?
On earnings-per-share growth, the picture is similar: Bullfrog AI Holdings, Inc.
Common Stock grew EPS 25. 9% year-over-year, compared to 10. 6% for Absci Corporation. Over a 3-year CAGR, BFRG leads at 225. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BFRG or ABSI?
Absci Corporation (ABSI) is the more profitable company, earning -41.
1% net margin versus -55. 7% for Bullfrog AI Holdings, Inc. Common Stock — meaning it keeps -41. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ABSI leads at -44. 5% versus -56. 5% for BFRG. At the gross margin level — before operating expenses — BFRG leads at 18. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — BFRG or ABSI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is BFRG or ABSI better for a retirement portfolio?
For long-horizon retirement investors, Absci Corporation (ABSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
Bullfrog AI Holdings, Inc. Common Stock (BFRG) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ABSI: -73. 4%, BFRG: -90. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between BFRG and ABSI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.